Blog

November is Pancreatic Cancer Awareness Month

by Ryan L. Thompson on 11/07/2013

This November, to mark Pancreatic Cancer Awareness Month, our law firm is focusing on awareness and prevention of this deadly disease, the fourth leading cause of cancer deaths.

According to the American Cancer Society, pancreatic cancer is the most lethal of cancers with an overall survival rate of only 6%. An estimated 45,000 Americans will be diagnosed with pancreatic cancer this year and more than 38,000 will die. There are no early detection tests, no effective long-term treatments, and unless caught in its earliest stages, there is no cure for pancreatic cancer.

Luckily, there are groups like Lustgarten Foundation, dedicated to finding a cure for this lethal disease by increasing funding and support for research into the biological mechanisms and clinical strategies related to the prevention, diagnosis, and treatment of pancreatic cancer.

Pancreatic cancer is often labeled a silent killer because its warning signs and symptoms go unnoticed until the cancer is in advanced stages. Even when there are early signs and symptoms, they are usually misdiagnosed as a less serious disease. 

Early symptoms of pancreatic cancer can include:

  • Anorexia or a diminished appetite
  • Jaundice
  • Nausea
  • Pain in the upper or middle abdomen
  • Weight loss

 According to the Mayo Clinic, risk factors for pancreatic cancer can include:

  • Being overweight or obese
  • Chronic inflammation of the pancreas (pancreatitis)
  • Diabetes
  • Personal or family history of pancreatic cancer
  • Smoking

 Despite the dismal outlook, the potential to survive a diagnosis of pancreatic cancer and live a full life does exist. This week the Huffington Post published an article “How I am Beating Pancreatic Cancer,” a touching story of a woman who is winning her fight against pancreatic cancer.

The threat of this deadly disease can be frightening, and the reality is, more often than not, devastating.

Sadly, some drugs prescribed to treat type II diabetes, including Byetta, Januvia and other incretin memetics have been linked to an increased risk of developing acute pancreatitis, which can and often does lead to the development of pancreatic cancer. 

At Watts Guerra, LLP we stand up to negligent drug manufacturers who fail to disclose serious side effects of the drugs they manufacture. Especially when the risk is something as devastating as pancreatic cancer. 

If you or a loved one developed pancreatitis or pancreas cancer during or after being treated for type II diabetes with Byetta, Januvia or any medication in the incretin memetics class of drugs, contact a lawyer at Watts Guerra, LLP.

 

Pancreatice Cancer 

Tags: Pharmaceutical Mass Torts

blog comments powered by Disqus